Front Row Advisors LLC Edwards Lifesciences Corp Transaction History
Front Row Advisors LLC
- $271 Million
- Q3 2024
A detailed history of Front Row Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Front Row Advisors LLC holds 240 shares of EW stock, worth $17,817. This represents 0.01% of its overall portfolio holdings.
Number of Shares
240
Previous 240
-0.0%
Holding current value
$17,817
Previous $22,000
31.82%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding EW
# of Institutions
1,350Shares Held
457MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.65 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.78 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.34 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.95 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$1 Billion0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $45.9B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...